SINOTHERAPEUTICS INC.

News Sinotherapeutics Inc.

Equities

688247

CNE100005PL9

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
9.4 ^CNY	+0.11%		-3.59%	-14.39%

04-29	Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-02	Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.	04-01	CI
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Sinotherapeutics Inc. announces an Equity Buyback for CNY 70 million worth of its shares.	02-20	CI
Sinotherapeutics Inc. authorizes a Buyback Plan.	02-18	CI
Sinotherapeutics Gets Nod for Mesalazine Tablets; Shares Drop 7%	02-05	MT
Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Sinotherapeutics' Unit Gets Registration Certificate for Sevelamer Carbonate Tablets	26/09/23	MT
Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange A Share Index	25/08/23	CI
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange Composite Index	25/08/23	CI
Sinotherapeutics Gets US FDA Nod for Arthritis Drug	10/08/23	MT
Sinotherapeutics Signs Product Licensing Deal With US Drugmaker Lannett	07/08/23	MT
FDA Greenlights Sinotherapeutics' Mesalazine Enteric-Coated Tablets	17/05/23	MT
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Sinotherapeutics Drug Selected in China's Centralized Drug Procurement	13/04/23	MT
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Sinotherapeutics’ Antifungal Drug Added to China’s Medical Insurance Catalog	19/01/23	MT
Sinotherapeutics Inc. has completed an IPO in the amount of CNY 424.8358 million.	22/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
688247 Stock
News Sinotherapeutics Inc.

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer